Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

Researchers improve cisplatin-induced ototoxicity model

Feb. 10, 2022

SENS-401 shows good local bioavailability in sensorineural hearing loss model

Feb. 9, 2022

Rockefeller University presents new LATS1 inhibitors

Sep. 1, 2021

Otonomy announces phase I/II study expansion for OTO-413 in speech-in-noise hearing difficulty

June 16, 2021

Frequency Therapeutics reports phase IIa data on FX-322 in sensorineural hearing loss

March 23, 2021

Gene therapy for TMPRSS3 hearing loss shows promise with late intervention in mouse model

March 8, 2021

Decibel Therapeutics presents DB-OTO for genetic hearing loss

Feb. 25, 2021

Novel model of age-related hearing loss with consistent flat cochlear epithelium phenotype

Feb. 25, 2021

Phase III trial of Otividex for Meniere's disease does not meet primary endpoint

Feb. 25, 2021

Targeting AMPK-alpha prevents drug-induced hair cell loss and hearing loss

Feb. 22, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...